Bone marrow transplant is moving forward slowly, |
Drug companies are interested in diseases that millions of people get, ... That's where the profits are. |
It's hard to get funding or people interested in trials, ... But because this is a lifelong, chronic problem, it has a greater impact. |
We're starting to understand the interaction of sickle blood with blood vessels, ... That's being now applied to treatments that actually improve outcome. |